EUSA Pharma Announces First Patient Enrolled in a Randomised Phase 3 Clinical Trial Investigating Siltuximab in Hospitalised Patients with COVID-19- or Another Respiratory...
HEMEL HEMPSTEAD, United Kingdom & BURLINGTON, Mass.--(BUSINESS WIRE)--Dec 17, 2020-- |!| Ludington
